Novo Nordisk Says Will Seek Approval of Obesity Drug Liraglutide Next Year

 
Novo Nordisk Says Will Seek Approval of Obesity Drug Liraglutide Next Year
click here

Investigational New Drug Application Cleared by FDA for OMS824 in Huntington’s Disease

Investigational New Drug Application Cleared by FDA for OMS824 in Huntington’s Disease

Takeda Begins Phase III Trial of Ixazomib, Multiple Myeloma Drug

Takeda Begins Phase III Trial of Ixazomib, Multiple Myeloma Drug

Biogen submits MS drug Plegridy, peginterferon beta-1a to FDA

Biogen submits MS drug Plegridy, peginterferon beta-1a to FDA

Breast Cancer Fighting Hormone Identified

Breast Cancer Fighting Hormone Identified

A new tumor-killer

A new tumor-killer

Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule proven to successfully kill tumor cells. This molecule is based on a natural protein present in human breast milk, which has been found to have strong and wide-ranging tumor killing properties when bound to certain lipids. Lipids are organic molecules … more…

Radioactive nanoparticles selectively target cancer cells

Radioactive nanoparticles selectively target cancer cells

Researchers at the University of Missouri have found a way to create radioactive nanoparticles that target lymphoma tumor cells wherever they may be in the body. Michael Lewis, an associate professor of oncology in the MU College of Veterinary Medicine, says being able to target secondary tumors is vital to successfully treating patients with progressive … more…